Systematic review of hyperbaric oxygen therapy for cerebral palsy: The state of the evidence

Marian McDonagh, Diane Morgan, Susan Carson, Barry S. Russman

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

A systematic review of the evidence was conducted on the benefits and adverse effects of hyperbaric oxygen treatment (HBOT) for cerebral palsy (CP). Studies of any HBOT regimen in patients with CP were included except for case reports and case series. Electronic databases (e.g. MEDLINE, EMBASE), professional society databases, and reference lists were searched to identify studies. Study quality was assessed using predefined criteria relevant to the study design. Two randomized controlled trials and four observational studies were identified. Best evidence came from a randomized controlled trial which found that HBOT at 1.75 atmospheres (atm) and 1.3atm of room air resulted in similar improvements in motor function (5-6%). Other outcomes also indicated no difference between the HBOT and room air. Observational studies reported improvements in motor function to a similar degree. Other evidence was insufficient to clarify the benefits and/or adverse effects of HBOT for CP. Both HBOT and pressurized room air resulted in improvements in motor function compared with baseline. Similar improvements were seen in the observational studies. Children undergoing HBOT were reported to experience adverse events, including seizures and the need for ear pressure equalization tube placement, but the incidence was unclear. Future research is needed to determine the efficacy of pressurized room air or non-pressurized oxygen in equivalent amounts by mask, compared with standard treatments.

Original languageEnglish (US)
Pages (from-to)942-947
Number of pages6
JournalDevelopmental Medicine and Child Neurology
Volume49
Issue number12
DOIs
StatePublished - Dec 2007

Fingerprint

Hyperbaric Oxygenation
Cerebral Palsy
Oxygen
Compressed Air
Observational Studies
Therapeutics
Randomized Controlled Trials
Air
Databases
Masks
Atmosphere
MEDLINE
Ear
Seizures
Pressure
Incidence

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Neuroscience(all)

Cite this

Systematic review of hyperbaric oxygen therapy for cerebral palsy : The state of the evidence. / McDonagh, Marian; Morgan, Diane; Carson, Susan; Russman, Barry S.

In: Developmental Medicine and Child Neurology, Vol. 49, No. 12, 12.2007, p. 942-947.

Research output: Contribution to journalArticle

@article{0b6dc93e946e407e88b3b9eab30b51bf,
title = "Systematic review of hyperbaric oxygen therapy for cerebral palsy: The state of the evidence",
abstract = "A systematic review of the evidence was conducted on the benefits and adverse effects of hyperbaric oxygen treatment (HBOT) for cerebral palsy (CP). Studies of any HBOT regimen in patients with CP were included except for case reports and case series. Electronic databases (e.g. MEDLINE, EMBASE), professional society databases, and reference lists were searched to identify studies. Study quality was assessed using predefined criteria relevant to the study design. Two randomized controlled trials and four observational studies were identified. Best evidence came from a randomized controlled trial which found that HBOT at 1.75 atmospheres (atm) and 1.3atm of room air resulted in similar improvements in motor function (5-6{\%}). Other outcomes also indicated no difference between the HBOT and room air. Observational studies reported improvements in motor function to a similar degree. Other evidence was insufficient to clarify the benefits and/or adverse effects of HBOT for CP. Both HBOT and pressurized room air resulted in improvements in motor function compared with baseline. Similar improvements were seen in the observational studies. Children undergoing HBOT were reported to experience adverse events, including seizures and the need for ear pressure equalization tube placement, but the incidence was unclear. Future research is needed to determine the efficacy of pressurized room air or non-pressurized oxygen in equivalent amounts by mask, compared with standard treatments.",
author = "Marian McDonagh and Diane Morgan and Susan Carson and Russman, {Barry S.}",
year = "2007",
month = "12",
doi = "10.1111/j.1469-8749.2007.00942.x",
language = "English (US)",
volume = "49",
pages = "942--947",
journal = "Developmental Medicine and Child Neurology",
issn = "0012-1622",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Systematic review of hyperbaric oxygen therapy for cerebral palsy

T2 - The state of the evidence

AU - McDonagh, Marian

AU - Morgan, Diane

AU - Carson, Susan

AU - Russman, Barry S.

PY - 2007/12

Y1 - 2007/12

N2 - A systematic review of the evidence was conducted on the benefits and adverse effects of hyperbaric oxygen treatment (HBOT) for cerebral palsy (CP). Studies of any HBOT regimen in patients with CP were included except for case reports and case series. Electronic databases (e.g. MEDLINE, EMBASE), professional society databases, and reference lists were searched to identify studies. Study quality was assessed using predefined criteria relevant to the study design. Two randomized controlled trials and four observational studies were identified. Best evidence came from a randomized controlled trial which found that HBOT at 1.75 atmospheres (atm) and 1.3atm of room air resulted in similar improvements in motor function (5-6%). Other outcomes also indicated no difference between the HBOT and room air. Observational studies reported improvements in motor function to a similar degree. Other evidence was insufficient to clarify the benefits and/or adverse effects of HBOT for CP. Both HBOT and pressurized room air resulted in improvements in motor function compared with baseline. Similar improvements were seen in the observational studies. Children undergoing HBOT were reported to experience adverse events, including seizures and the need for ear pressure equalization tube placement, but the incidence was unclear. Future research is needed to determine the efficacy of pressurized room air or non-pressurized oxygen in equivalent amounts by mask, compared with standard treatments.

AB - A systematic review of the evidence was conducted on the benefits and adverse effects of hyperbaric oxygen treatment (HBOT) for cerebral palsy (CP). Studies of any HBOT regimen in patients with CP were included except for case reports and case series. Electronic databases (e.g. MEDLINE, EMBASE), professional society databases, and reference lists were searched to identify studies. Study quality was assessed using predefined criteria relevant to the study design. Two randomized controlled trials and four observational studies were identified. Best evidence came from a randomized controlled trial which found that HBOT at 1.75 atmospheres (atm) and 1.3atm of room air resulted in similar improvements in motor function (5-6%). Other outcomes also indicated no difference between the HBOT and room air. Observational studies reported improvements in motor function to a similar degree. Other evidence was insufficient to clarify the benefits and/or adverse effects of HBOT for CP. Both HBOT and pressurized room air resulted in improvements in motor function compared with baseline. Similar improvements were seen in the observational studies. Children undergoing HBOT were reported to experience adverse events, including seizures and the need for ear pressure equalization tube placement, but the incidence was unclear. Future research is needed to determine the efficacy of pressurized room air or non-pressurized oxygen in equivalent amounts by mask, compared with standard treatments.

UR - http://www.scopus.com/inward/record.url?scp=36549077801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36549077801&partnerID=8YFLogxK

U2 - 10.1111/j.1469-8749.2007.00942.x

DO - 10.1111/j.1469-8749.2007.00942.x

M3 - Article

C2 - 18039243

AN - SCOPUS:36549077801

VL - 49

SP - 942

EP - 947

JO - Developmental Medicine and Child Neurology

JF - Developmental Medicine and Child Neurology

SN - 0012-1622

IS - 12

ER -